Chris Hutton

Chris Hutton is the CEO of DRA Pharmaceuticals, a well-regarded South African laboratory that focuses on pharmaceutical expertise and regulatory compliance. He was in the news for his partnership with Moroccan company Cannaflex, which successfully launched the medical cannabis product Beldiya Plus°, emphasizing the importance of scientifically validated treatments in Africa.